Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
40,762,262
-
Number of holders
-
98
-
Total 13F shares, excl. options
-
17,288,638
-
Shares change
-
+14,814,051
-
Total reported value, excl. options
-
$1,179,671,046
-
Value change
-
+$1,018,686,046
-
Number of buys
-
93
-
Price
-
$69.02
Significant Holders of Pulmonx Corp - COM (LUNG) as of Q4 2020
98 filings reported holding LUNG - Pulmonx Corp - COM as of Q4 2020.
Pulmonx Corp - COM (LUNG) has 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17,288,638 shares
of 40,762,262 outstanding shares and own 42% of the company stock.
Largest 10 shareholders include KPCB XIII Associates, LLC (1,421,386 shares), RTW INVESTMENTS, LP (1,129,600 shares), GILDER GAGNON HOWE & CO LLC (1,102,602 shares), VANGUARD GROUP INC (1,098,759 shares), BlackRock Inc. (850,608 shares), ABG Innovation Capital Partners III GP Ltd (833,333 shares), PRIMECAP MANAGEMENT CO/CA/ (732,500 shares), Capital World Investors (679,430 shares), FMR LLC (574,964 shares), and Rock Springs Capital Management LP (500,000 shares).
This table shows the top 98 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.